{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-021615","form_type":"8-K","ticker":"PLSE","cik":"0001625101","company_name":"PULSE BIOSCIENCES, INC.","filed_at":"2024-06-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.303510+00:00","generated_at":"2026-06-01T00:36:41.814842+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Pulse Biosciences rights offering oversubscribed, raises $60M; Duggan to hold ~72%","bullets":["Offering oversubscribed at 138%, receiving over $83M in subscriptions vs $60M limit.","Expected gross proceeds of $60M from sale of ~6M units at $10/unit.","Executive Chairman Robert Duggan subscribed for ~5M units, boosting his ownership to ~72%.","Warrants could generate up to $66M additional proceeds if exercised; exercise price $11/share.","Units consist of one share and two warrants; warrants expire in five years with redemption conditions."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-021615","json":"https://secwatch.observer/filing/0001437749-24-021615.json","markdown":"https://secwatch.observer/filing/0001437749-24-021615.md","text":"https://secwatch.observer/filing/0001437749-24-021615.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1625101/000143774924021615/0001437749-24-021615-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1625101/000143774924021615/plse20240627_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T00:36:41.814842+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}